Results
|
|
241.
|
|
|
|
242.
|
|
|
|
243.
|
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. [electronic resource] by
- Belshe, R B
- Clements, M L
- Dolin, R
- Graham, B S
- McElrath, J
- Gorse, G J
- Schwartz, D
- Keefer, M C
- Wright, P
- Corey, L
Producer: 19931228
In:
The Journal of infectious diseases vol. 168
Availability: No items available.
|
|
|
244.
|
Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children. [electronic resource] by
- Kapikian, A Z
- Flores, J
- Hoshino, Y
- Midthun, K
- Gorziglia, M
- Green, K Y
- Chanock, R M
- Potash, L
- Sears, S D
- Clements, M L
Producer: 19890911
In:
Reviews of infectious diseases vol. 11 Suppl 3
Availability: No items available.
|
|
|
245.
|
|
|
|
246.
|
The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil. [electronic resource] by
- Levine, M M
- Black, R E
- Clements, M L
- Cisneros, L
- Saah, A
- Nalin, D R
- Gill, D M
- Craig, J P
- Young, C R
- Ristaino, P
Producer: 19820527
In:
The Journal of infectious diseases vol. 145
Availability: No items available.
|
|
|
247.
|
|
|
|
248.
|
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. [electronic resource] by
- Graham, B S
- Belshe, R B
- Clements, M L
- Dolin, R
- Corey, L
- Wright, P F
- Gorse, G J
- Midthun, K
- Keefer, M C
- Roberts, N J
Producer: 19920825
In:
The Journal of infectious diseases vol. 166
Availability: No items available.
|
|
|
249.
|
Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. [electronic resource] by
- Snyder, M H
- Betts, R F
- DeBorde, D
- Tierney, E L
- Clements, M L
- Herrington, D
- Sears, S D
- Dolin, R
- Maassab, H F
- Murphy, B R
Producer: 19880220
In:
Journal of virology vol. 62
Availability: No items available.
|
|
|
250.
|
A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. [electronic resource] by
- Rao, A K
- Schapira, M
- Clements, M L
- Niewiarowski, S
- Budzynski, A Z
- Schmaier, A H
- Harpel, P C
- Blackwelder, W C
- Scherrer, J R
- Sobel, E
Producer: 19880504
In:
The New England journal of medicine vol. 318
Availability: No items available.
|
|
|
251.
|
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. [electronic resource] by
- Karron, R A
- Wright, P F
- Newman, F K
- Makhene, M
- Thompson, J
- Samorodin, R
- Wilson, M H
- Anderson, E L
- Clements, M L
- Murphy, B R
Producer: 19951228
In:
The Journal of infectious diseases vol. 172
Availability: No items available.
|
|
|
252.
|
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. [electronic resource] by
- Levine, M M
- Black, R E
- Brinton, C C
- Clements, M L
- Fusco, P
- Hughes, T P
- O'Donnell, S
- Robins-Browne, R
- Wood, S
- Young, C R
Producer: 19821221
In:
Scandinavian journal of infectious diseases. Supplementum vol. 33
Availability: No items available.
|
|
|
253.
|
Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever. [electronic resource] by
- Clements, M L
- Wisseman, C L
- Woodward, T E
- Fiset, P
- Dumler, J S
- McNamee, W
- Black, R E
- Rooney, J
- Hughes, T P
- Levine, M M
Producer: 19831220
In:
The Journal of infectious diseases vol. 148
Availability: No items available.
|
|
|
254.
|
Comparison of the immune response to recombinant gp120 in humans and chimpanzees. [electronic resource] by
- Berman, P W
- Eastman, D J
- Wilkes, D M
- Nakamura, G R
- Gregory, T J
- Schwartz, D
- Gorse, G
- Belshe, R
- Clements, M L
- Byrn, R A
Producer: 19940922
In:
AIDS (London, England) vol. 8
Availability: No items available.
|
|
|
255.
|
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network. [electronic resource] by
- Keefer, M C
- Graham, B S
- Belshe, R B
- Schwartz, D
- Corey, L
- Bolognesi, D P
- Stablein, D M
- Montefiori, D C
- McElrath, M J
- Clements, M L
Producer: 19950420
In:
AIDS research and human retroviruses vol. 10
Availability: No items available.
|
|
|
256.
|
The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children. [electronic resource] by
- Steinhoff, M C
- Halsey, N A
- Fries, L F
- Wilson, M H
- King, J
- Burns, B A
- Samorodin, R K
- Perkis, V
- Murphy, B R
- Clements, M L
Producer: 19910528
In:
The Journal of infectious diseases vol. 163
Availability: No items available.
|
|
|
257.
|
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. [electronic resource] by
- Dolin, R
- Graham, B S
- Greenberg, S B
- Tacket, C O
- Belshe, R B
- Midthun, K
- Clements, M L
- Gorse, G J
- Horgan, B W
- Atmar, R L
Producer: 19910118
In:
Annals of internal medicine vol. 114
Availability: No items available.
|
|
|
258.
|
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. [electronic resource] by
- Graham, B S
- Matthews, T J
- Belshe, R B
- Clements, M L
- Dolin, R
- Wright, P F
- Gorse, G J
- Schwartz, D H
- Keefer, M C
- Bolognesi, D P
Producer: 19930330
In:
The Journal of infectious diseases vol. 167
Availability: No items available.
|
|
|
259.
|
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. [electronic resource] by
- Graham, B S
- Gorse, G J
- Schwartz, D H
- Keefer, M C
- McElrath, M J
- Matthews, T J
- Wright, P F
- Belshe, R B
- Clements, M L
- Dolin, R
Producer: 19941101
In:
The Journal of infectious diseases vol. 170
Availability: No items available.
|
|
|
260.
|
Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children. [electronic resource] by
- Belshe, R B
- Karron, R A
- Newman, F K
- Anderson, E L
- Nugent, S L
- Steinhoff, M
- Clements, M L
- Wilson, M H
- Hall, S L
- Tierney, E L
Producer: 19920911
In:
Journal of clinical microbiology vol. 30
Availability: No items available.
|